[Prevention and therapy of urinary tract infection due to indwelling catheterization (following vaginal surgery) with special reference to follow-up studies].
D005260:Female; D005500:Follow-Up Studies; D005831:Genital Diseases, Female / Q000601:surgery*; D006801:Humans; D007044:Hysterectomy; D009268:Nalidixic Acid / Q000627:therapeutic use; D009582:Nitrofurantoin / Q000627:therapeutic use; D011183:Postoperative Complications / Q000517:prevention & control*; D013997:Time Factors; D014546:Urinary Catheterization / Q000009:adverse effects*; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control*; D014621:Vagina / Q000601:surgery*
D009268:Nalidixic Acid; D009582:Nitrofurantoin
Zur Prophylaxe und Therapie des Harnweginfekts bei Dauerkatheter (nach vaginalen Operationen) unter besonderer Berücksichtigung von Nachuntersuchungen.